Senior Business Advisor/
Mr. Weaver started his consulting practice, Aimattech Consulting LLC, in 1985 after completing a corporate turnaround for a division of Warner-Lambert. He performed due diligence on a startup for Sequoia Capital. He also helped a number of companies create Business Plans and marketing strategies in the San Francisco Bay area.
A results-driven leader and innovative problem solver with an entrepreneurial spirit and sense of urgency. He has over 40 years of diversified management experience, which includes: global profit/loss responsibility (Johnson & Johnson), turning around troubled business operations (Warner-Lambert). While as VP of Sales & Marketing at Somanetics Corp. (SMTS) he successfully launched the first Cerebral Oximeter in the global market. He has helped raise private (angel), venture (VC) and public (IPO) capital of over $35 million.
In the past, Mr. Weaver was a Board Member for the Detroit chapter of Association for Corporate Growth and is still active in M&A activities.
Mr. Weaver served as an Executive-in-Residence (Standby CEO, 2007 – 2009) / Fund Manager at the Pittsburgh Life Science Greenhouse where he was responsible for global recruiting, coaching, mentoring, analyzing business plans and strategies and making funding recommendations for growing life science companies in the Pittsburgh area. Mr. Weaver met with institutional and angel investors to review potential Pittsburgh investments and assisted portfolio companies in Business Plan preparation and investor presentations.
David most recently was CEO (2010 – 2015) of Blaze Medical Devices, LLC an early stage medical device company. Blaze would offer the first standardized and commercial device that can be used to measure sub-hemolytic damage of red blood cells. He moved Blaze from “concept” to achieving “proof of concept” and a working prototype, secured 4 issued patents, 2 NIH Grants and raised $1.3 M in angel funding in a billion-dollar underserved market.
He is Founder/Chairman of Great Lakes Angels the first angel group in Michigan (2002). The Great Lakes Angels selected a number of successful companies to present that went on to have very successful exits, such as: ONL Therapeutics, Accuri Cytometers. He also was a Founding Member for the MIT Enterprise Forum of the Great Lakes, a Founding Member of Michigan Venture Capital Association, and a Charter Member of the Angel Capital Association.